Mark Steven Duxon
Founder at Transpharmation Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Neil Upton | M | 66 |
Transpharmation Ltd.
 Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | 14 years |
| Joseph Araujo | M | 50 |
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022.
Vivocore, Inc.
 Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | 3 years |
| Richard Patricio | M | 50 |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | - |
| Lai Yin Chan | F | - |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | - |
| Norton Milgram | M | - |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | - |
| Col Taylor | F | - |
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | - |
| Ryan Filson | M | - |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | - |
| Andrew Barber | M | - |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 6 | 75.00% |
| United Kingdom | 3 | 37.50% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Steven Duxon
- Personal Network
